Integration of novel biomarkers in prospective trials: biological insights from CHOICE-01
Saved in:
| Main Authors: | Edward Christopher Dee, Puneeth Iyengar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-12-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-024-02078-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial
by: Jia Zhong, et al.
Published: (2024-12-01) -
Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles
by: Stephen Burgess, et al.
Published: (2024-02-01) -
TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol
by: Colin I Tang, et al.
Published: (2019-08-01) -
The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers
by: Anna Sicuranza, et al.
Published: (2025-05-01) -
Apelin-13 as a novel diagnostic laboratory biomarker in thromboembolic disorders: a review of literature with prospective insights
by: Mehdi Karimi, et al.
Published: (2024-12-01)